These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2160523)

  • 1. Tuftsin increases survival in murine peritoneal carcinomatosis.
    Chu DZ; Nishioka K
    J Biol Response Mod; 1990 Apr; 9(2):264-7. PubMed ID: 2160523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential use of tuftsin in treatment of candida peritonitis in a murine model.
    Levy R; Kain Z; Chaimovitz C; Fridkin M; Segal S; Alkan M
    J Biol Regul Homeost Agents; 1989; 3(2):71-8. PubMed ID: 2554684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of an antibody to vascular endothelial growth factor receptor-2 on survival, tumor vascularity, and apoptosis in a murine model of colon carcinomatosis.
    Shaheen RM; Tseng WW; Vellagas R; Liu W; Ahmad SA; Jung YD; Reinmuth N; Drazan KE; Bucana CD; Hicklin DJ; Ellis LM
    Int J Oncol; 2001 Feb; 18(2):221-6. PubMed ID: 11172585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity of albendazole against the human colorectal cancer cell line HT-29: in vitro and in a xenograft model of peritoneal carcinomatosis.
    Pourgholami MH; Akhter J; Wang L; Lu Y; Morris DL
    Cancer Chemother Pharmacol; 2005 May; 55(5):425-32. PubMed ID: 15565325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraperitoneal treatment using taxol is effective for experimental peritoneal carcinomatosis in a rat model.
    Hribaschek A; Ridwelski K; Pross M; Meyer F; Kuhn R; Halangk W; Boltze C; Lippert H
    Oncol Rep; 2003; 10(6):1793-8. PubMed ID: 14534698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of peritoneal carcinomatosis in mice with combination hyperthermal intraperitoneal chemotherapy and IL-2.
    Bevanda M; Orsolic N; Basic I; Vukojevic K; Benkovic V; Horvat Knezevic A; Lisicic D; Dikic D; Kujundzic M
    Int J Hyperthermia; 2009 Mar; 25(2):132-40. PubMed ID: 19337913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of intraperitoneally administered recombinant murine granulocyte-macrophage colony-stimulating factor (rmGM-CSF) on the cytotoxic potential of murine peritoneal cells.
    Klimp AH; Regts J; Scherphof GL; de Vries EG; Daemen T
    Br J Cancer; 1999 Jan; 79(1):89-94. PubMed ID: 10408698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritoneal and splenic macrophage functions in the tumor-bearing host.
    Gardner TE; Naama H; Daly JM
    J Surg Res; 1995 Aug; 59(2):305-10. PubMed ID: 7637346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of experimental murine pancreatic peritoneal carcinomatosis with fibroblasts genetically modified to express IL12: a role for peritoneal innate immunity.
    Péron JM; Bureau C; Gourdy P; Lulka H; Souque A; Calippe B; Selves J; Al Saati T; Bernad J; Cordelier P; Couderc B; Pradayrol L; Pipy B; Buscail L; Vinel JP
    Gut; 2007 Jan; 56(1):107-14. PubMed ID: 16891358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arsenic trioxide (As2O3) sensitivity of carcinoma cell lines and cancer cells from patients with carcinomatosis peritonei.
    Moon Y; Park G; Kim Y; Kim M; Lim J; Pai SH; Lee EJ; Kang CS; Han K
    Ann Clin Lab Sci; 2004; 34(3):271-6. PubMed ID: 15487701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of treatment with free and liposomized albendazole on selected immunological parameters and cyst growth in mice infected with Echinococcus multilocularis.
    Dvoroznáková E; Hrcková G; Borosková Z; Velebný S; Dubinský P
    Parasitol Int; 2004 Dec; 53(4):315-25. PubMed ID: 15464441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicity, stability and pharmacokinetics of amphotericin B in immunomodulator tuftsin-bearing liposomes in a murine model.
    Khan MA; Owais M
    J Antimicrob Chemother; 2006 Jul; 58(1):125-32. PubMed ID: 16709592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intraperitoneal cisplatin plus epinephrine and surgical debulking for the treatment of advanced peritoneal carcinomatosis in the rat].
    Benoit L; Duvillard C; Beltramo JL; Brunet-Lecomte P; Chauffert B
    Gastroenterol Clin Biol; 2000 Jan; 24(1):26-30. PubMed ID: 10679584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary restriction augments superoxide generation in mouse peritoneal macrophages: an investigation using a chemiluminescence probe specific for superoxide anion.
    Hishinuma K; Hosono A; Mashiko S; Inaba H; Kimura S
    Int J Vitam Nutr Res; 1989; 59(3):314-8. PubMed ID: 2557295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respiratory burst in peritoneal exudate cells in response to a modified tuftsin.
    Singh SP; Chhabra R; Srivastava VM
    Experientia; 1992 Oct; 48(10):994-6. PubMed ID: 1330671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity of tuftsin on murine melanoma in vivo.
    Noyes RD; Babcock GF; Nishioka K
    Cancer Treat Rep; 1981; 65(7-8):673-5. PubMed ID: 6894714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuftsin: a naturally occurring immunopotentiating factor. I. In vitro enhancement of murine natural cell-mediated cytotoxicity.
    Phillips JH; Babcock GF; Nishioka K
    J Immunol; 1981 Mar; 126(3):915-21. PubMed ID: 6893996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of peritoneal cells on tumors cells growth in vitro.
    Salwa J
    Arch Immunol Ther Exp (Warsz); 1995; 43(1):37-41. PubMed ID: 8744682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the activation and interleukin-1 production of mouse peritoneal macrophages by three types of purified carrageenan.
    Okuda Y; Hanazawa S
    Josai Shika Daigaku Kiyo; 1986; 15(3):557-66. PubMed ID: 3493820
    [No Abstract]   [Full Text] [Related]  

  • 20. Intraperitoneal chemotherapy with hydroxycamptothecin reduces peritoneal carcinomatosis: results of an experimental study.
    Li PC; Chen LD; Zheng F; Li Y
    J Cancer Res Clin Oncol; 2008 Jan; 134(1):37-44. PubMed ID: 17665213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.